Understanding how a specific protein regulates inflammation in immune disorders
Regulation of Proinflammatory Cytokine Responses by a Caspase-8-N4BP1 Axis
This study is looking at how a protein called N4BP1 helps control inflammation in people with autoimmune lymphoproliferative syndrome (ALPS), and it hopes to find new ways to improve treatments for patients by understanding how certain gene changes affect the immune system.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10918129 on NIH RePORTER |
What this research studies
This research investigates the role of a protein called N4BP1 in regulating inflammatory responses in immune disorders, particularly focusing on autoimmune lymphoproliferative syndrome (ALPS). The study explores how mutations in caspase-8 and its interactions with N4BP1 affect the immune system's ability to control inflammation and apoptosis. By examining the mechanisms of cytokine production in immune cells, the research aims to uncover new insights into how these processes can be modulated for therapeutic purposes. Patients may benefit from a better understanding of their condition and potential new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with autoimmune lymphoproliferative syndrome (ALPS) or related immune disorders.
Not a fit: Patients with non-autoimmune conditions or those not affected by immune dysregulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that better control inflammation in patients with autoimmune disorders.
How similar studies have performed: Previous research has shown promising results in understanding immune regulation through similar pathways, indicating potential for success in this area.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Gitlin, Alexander — Sloan-Kettering Inst Can Research
- Study coordinator: Gitlin, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.